DXCM FY 2024 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$4.0B+11.3% YoY

Gross Profit

$2.4B60.5% margin

Operating Income

$600M14.9% margin

Net Income

$576M14.3% margin

EPS (Diluted)

$1.42

Cash Flow

Operating Cash Flow

$990M

Free Cash Flow

$631M

Stock-Based Comp.

$170M

Balance Sheet

Total Assets

$6.5B

Total Liabilities

$4.4B

Stockholders' Equity

$2.1B

Cash & Equivalents

$606M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.0B	$3.6B	+11.3%
Gross Profit	$2.4B	$2.3B	+6.5%
Operating Income	$600M	$598M	+0.4%
Net Income	$576M	$542M	+6.4%